Pro-Dex manufactures autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets.
1/
Probably a difficult one to put in my 'circle of competence' but might be worth trying.
Larger customers contract $PDEX rather than building in-house. Pro-Dex saves them the hassle of getting FDA approval and the risk of wasting time and capital.
2/
Customer concentration is probably the biggest risk and the chance of any major customer developing in-house is definitely a threat.
$PDEX have recently doubled their R&D and lowering margins from 20% down to 11%. Recently increased manufacturing ability with a new building
3/
In the short-term this has hurt the bottom line. But could play a key role in improving products and creating new products to grow volumes with current customers and potentially even expand into new markets. Expansion into Europe could be a catalyst.
4/
$PDEX has grown revenues at a 15% CAGR over the past 5 years, whilst EBIT CAGR over the same period was a much more impressive ~30%. The average 5Y ROE is ~20%.
Over the past 18months they have spent a large amount of capex $9m, but ~$8m could be classed as 'growth' capex.
5/
Typical capex is less than $1m. For reference, they generated $38m in revenue in FY21.
If we normalise earnings with a ~20% margin, $PDEX is currently trading at 12x earnings. Albeit, adjustments need to made to make the valuation seem appealing.
6/
Applying lower, more conservative margins prices them at around ~15-18x earnings. Which is probably a fair valuation.
It is a high ROIC, capital-light business model likely to grow EPS in the high-teens whilst expanding their manufacturing capacity.
7/
But the customer concentration may justify the valuation. Being an illiquid micro-cap, the market may offer a better price in the future
Either way it's an interesting name to follow. I'm only at the surface and reasonable chance of passing due to being outside my circle.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Tencent acquired a 40% stake in Epic Games back in 2012. Well before #Fortnite became one of the most popular games of all-time
2/
Epic Games is still a private company so it is difficult to assign a valuation.
A group of Australian investors acquired a small stake at a US$42 Billion valuation in November 2021.
3/
The investors told reporters they had paid 8.3x TTM revenues.
They also said that according to material shown to them, they paid 6-8x NTM sales. This gives us an insight into revenue and expected growth for Epic Games.
$SPOT is a dominant market leader in music streaming, above $GOOGL, $AAPL & $AMZN.
They are also now market leader in podcasts, taking over $AAPL last year.
2/
After a 46% decline from ATH, $SPOT now trades at ~3x NTM sales and ~11x NTM gross profit.
If gross margins expand in FY22, it maybe be closer to 9-10x gross profit.
3/
@TSOH_Investing made an interesting point of $SPOT possibly being the only company below a $50 Billion market cap with the potential of reaching 1 billion MAU.
As of Q3 2021, 24% of total revenue came from domestic gaming & 8% from international gaming, so 32% overall.
2/
Tencent’s LTM revenue is $87b, therefore $27.8b came from gaming.
If we look at the $MSFT acquisition of $ATVI for $68.7b as a guide, they are paying 7.6x revenues for the gaming business.
3/
$TCEHY gaming business at 7.6x sales is worth $211 billion.
Tencent’s gaming business is a faster growing & higher quality business compared to $ATVI with a much lower customer acquisition cost and incredible exposure through WeChat & QQ.